Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

NCT: NCT06382207 · COMPLETED

NCT IDNCT06382207
StatusCOMPLETED
Start Date2025-01-17
Completion2026-04-29
SponsorVirginia Commonwealth University (OTHER)
First posted
Last updated

Brief Summary

When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.

Frequently Asked Questions

What is Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs?

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs is a clinical trial registered under NCT06382207. Current status: COMPLETED.

What is the status of NCT06382207?

The current status of NCT06382207 (Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs) is: COMPLETED.

When did Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs start?

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs started on 2025-01-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.